Sepracor CEO Stepping Down In Reorganization
Marlborough-based Sepracor Inc.'s President and CEO, Adrian Adams, is stepping down as part of the company's merger with Dainippon Sumitomo Pharma America Inc.
The merger between Sepracor and DSP America is expected to be complete by April, and the two companies will operate under the Sepracor name.
Saburo Hamanaka, a director at Sepracor will take over as chairman of the company while Mark Iwicki, an executive vice president at the company will become president and chief operating officer.
Adams has become CEO of Inspire Pharmaceuticals in North Carolina.
Sepracor and DSP America, which is headquartered in Fort Lee, N.J., are both wholly-owned subsidiaries of the Japanese company Dainippon Sumitomo Pharma Co., Ltd.
DSP Co. purchased Sepracor for $2.6 billion in October. Sepracor markets the sleeping drug Lunesta.
WBJ Web Partners
Most Recent
Most Recent
0 Comments